Radiation therapy and serum salivary amylase in head and neck cancer

Francesca De Felice; Mario Tombolini; Angela Musella; Francesco Marampon; Vincenzo Tombolini; Daniela Musio

doi:10.18632/oncotarget.18763

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Radiation therapy and serum salivary amylase in head and neck cancer

Francesca De Felice _, Mario Tombolini, Angela Musella, Francesco Marampon, Vincenzo Tombolini and Daniela Musio

PDF | HTML | How to cite

Oncotarget. 2017; 8:90496-90500. https://doi.org/10.18632/oncotarget.18763

Metrics: PDF 1338 views | HTML 2033 views | ?

Abstract

Francesca De Felice1, Mario Tombolini2, Angela Musella3, Francesco Marampon4, Vincenzo Tombolini1 and Daniela Musio1

1Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

2Department Organs of Sense, Policlinico Umberto I, “Sapienza”, University of Rome, Rome, Italy

3Department of Gynecology, Obstetrics and Urological Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy

4Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy

Correspondence to:

Francesca De Felice, email: [email protected]

Keywords: amylase, head and neck cancer, radiotherapy, dose, salivary glands

Received: May 07, 2017 Accepted: June 10, 2017 Published: June 28, 2017

ABSTRACT

Radiation therapy (RT) is a valid treatment option for head and neck cancer (HNC). The risk of RT-induced toxicities is significant, especially due to extended treatment fields. The raise in amylase activity is strictly dependent on the volume of salivary glands included in the irradiated target volume and it is firmly related to the dose. The aim of this review is to report the effects on salivary amylase activity after radiation exposure of salivary glands, in patients with HNC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18763

Publication Alerts

Reviews:

Radiation therapy and serum salivary amylase in head and neck cancer

Abstract